Experience

Rebellion

• Sweden
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Founder & CEO

  • Sep 2020 - Present

  Rebellion is a long-term owner and developer of small and medium-sized businesses. Through acquisition, we aim to build an industrial group consisting of market-leading niche companies with robust cash flows and sustainable growth. Rebellion is a long-term owner and developer of small and medium-sized businesses. Through acquisition, we aim to build an industrial group consisting of market-leading niche companies with robust cash flows and sustainable growth.



Serendipity

• Stockholm, Sweden

• CEO

  • Oct 2015 - Jan 2019

  Serendipity Ixora is a Swedish investment company with proven track record in building and growing companies, often with highly complex and nisched products. The portfolio currently consists of companies within cleantech, biotech, medtech, advanced materials, and animal health. Serendipity's management team is the largest shareholder in Serendipity and takes an active role in the business operations as well as in the strategic management of the portfolio companies. Serendipity Ixora is a Swedish investment company with proven track record in building and growing companies, often with highly complex and nisched products. The portfolio currently consists of companies within cleantech, biotech, medtech, advanced materials, and animal health. Serendipity's management team is the largest shareholder in Serendipity and takes an active role in the business operations as well as in the strategic management of the portfolio companies.



Serendipity Group AB

• Sweden
• Investment Management

• Vice President of Business Development

  • Jan 2013 - Oct 2015

• Cheif Operating Officer

  • May 2011 - Dec 2012

• Division Manager

  • Jan 2009 - May 2011



Abera Bioscience AB

• Sweden
• Biotechnology Research
• 1 - 100 Employee

• CEO

  • Dec 2012 - Jun 2015

  Abera develops innovative platforms for vaccine development and has a portfolio of vaccine candidates under development based on its proprietary technology. Abera develops innovative platforms for vaccine development and has a portfolio of vaccine candidates under development based on its proprietary technology.



Xbrane Biopharma AB

• Sweden
• Biotechnology
• 1 - 100 Employee

• Interim CEO

  • Sep 2012 - Dec 2012

  Xbrane Bioscience is developing a portfolio of innovative technologies, including platforms for the development of multivalent vaccines and the efficient production of proteins. Xbrane Bioscience is developing a portfolio of innovative technologies, including platforms for the development of multivalent vaccines and the efficient production of proteins.



BinaryBio AB

• CEO

  • Apr 2010 - Dec 2012

  BinaryBio AB is a Swedish company based on scientifically leading research in the field of bioinformatics and distributed computing. Working closely with the Center for Biomembrane Research (CBR) at Stockholm University (SU) – a leading center for biomembrane research – and the Royal Institute of Technology (KTH), BinaryBio offers software solutions for protein modeling, protein structure determination, docking, simulation and technologies for distributed computing. BinaryBio AB is a Swedish company based on scientifically leading research in the field of bioinformatics and distributed computing. Working closely with the Center for Biomembrane Research (CBR) at Stockholm University (SU) – a leading center for biomembrane research – and the Royal Institute of Technology (KTH), BinaryBio offers software solutions for protein modeling, protein structure determination, docking, simulation and technologies for distributed computing.